The Third Circuit sided with the FTC in finding that the proposed merger was likely to have anti-competitive effects in violation of Section 7 of the Clayton Act, 15 U.S.C. Section 18. That section prohibits mergers whose impact “may be substantially to lessen competition, or to tend to create a monopoly.” The court held that, although the district court had correctly identified the “hypothetical monopolist” test, i.e., whether a hypothetical monopolist could impose a small but significant nontransitory increase in price (SSNIP) in the proposed market, as the appropriate means of analyzing the geographic markets proposed by the parties, it had improperly formulated and applied the test.
While Third Circuit precedent suggests that a decision on market definition is often a factual question that is subject to the clearly erroneous standard of review, the Third Circuit determined that the application of the hypothetical monopolist test invokes a legal standard, the application of which is subject to plenary review. Thus, the Third Circuit afforded to the government a favorable standard of review. Moreover, in contrast to the District Court, which approached the case with a somewhat holistic view that considered the merger in light of the realities of the ever-changing health care industry, the Third Circuit took a more formalistic approach focused on traditional antitrust jurisprudence and economics.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]